For instance, a study reported that about 45% of MDS/AML families had a mutation in genes including RUNX1, TERT, ANKRD26, CEBPA, DDX41, ETV6, GATA2, TERC, and TP53 [109]. This evidence concerns the gene CEBPA and acute myeloid leukemia.